Trial Profile
Clinical trial of PAT-LM1 for the treatment of lymphomas
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 23 Apr 2014
Price :
$35
*
At a glance
- Drugs PAT LM1 (Primary)
- Indications Lymphoma
- Focus Adverse reactions
- 23 Apr 2014 New trial record
- 24 Mar 2014 Patrys has commenced the manufacturing process to produce PAT-LM1 for a future clinical trial, according to a company media release.